Immunomodulatory treatment in multiple sclerosis: experience at a Brazilian center with 390 patients

Since 1993 the Federal Drug Administration approved the use of immunomodulatory therapy in multiple sclerosis (MS), modifying the natural course of disease, as demonstrate our experience in treatment of MS patients at the MS Treatment Center (CATEM). OBJECTIVE: To evaluate patient behavior using imm...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Charles Peter Tilbery, Maria Fernanda Mendes, Bianca Etelvina Santos de Oliveira, Rodrigo Barbosa Thomaz, Giorge Ribeiro Kelian
Format:	Artigo
Jezik:	Inglês
Izdano:	Thieme Revinter Publicações 2006-03-01
Serija:	Arquivos de Neuro-Psiquiatria
Teme:	multiple sclerosis immunomodulatory therapy treatment failure
Online dostop:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2006000100011&tlng=en
Oznake:	Označite Brez oznak, prvi označite!